When one young-blood company closes, another opens

You may be familiar with the trials and tribulations of Ambrosia, the startup charging $8,000 for infusions of blood from young donors. That caught the attention of Stephen Colbert, and of the FDA, which issued a stern warning earlier this year that prompted the company to halt its operations. Now, Ambrosia appears to have shut down altogether.

That's according to a new story from Business Insider, which cited an email from the startup's founder, Jesse Karmazin. In its place, Karmazin reportedly wrote, he's started a new company to offer blood transfusions. Its name? Ivy Plasma, which could be easily mistaken for a college admissions consultancy.

This time around, the branding may focus less on blood that is youthful. Karmazin told STAT by email yesterday that Ivy Plasma won't be looking for donors of only specific ages to supply blood. "The age range is potentially anyone," he wrote.